It's an interesting bio.
The nearest competitor, NA1 (NoNo) is currently on Phase 3 trial (expected to completed December 2020).
But AGN's is still pre-clinical.
It takes NoNo 8 years from Phase 1 to Phase 3.
I think it's a long way to go.
ARGENICA THERAPEUTICS LIMITED IPO Analysis, page-2
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
67.5¢ |
Change
0.025(3.85%) |
Mkt cap ! $83.51M | |||
| Open | High | Low | Value | Volume |
| 65.0¢ | 69.5¢ | 65.0¢ | $172.5K | 257.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 600 | 67.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 68.5¢ | 6371 | 1 |
View Market Depth
| Last trade - 11.51am 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
67.0¢ |
Change
0.025 ( 1.52 %) |
||||
| Open | High | Low | Volume | ||
| 65.0¢ | 69.0¢ | 65.0¢ | 58171 | ||
| Last updated 11.51am 15/05/2024 ? | |||||
| AGN (ASX) Chart |